Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Mackenzie IR, Neumann M, Cairns NJ, Munoz DG, Isaacs AM.

J Mol Neurosci. 2011 Nov;45(3):402-8. doi: 10.1007/s12031-011-9551-1. Epub 2011 May 21. Review.

PMID:
21603977
[PubMed - indexed for MEDLINE]
2.

A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.

Lashley T, Rohrer JD, Bandopadhyay R, Fry C, Ahmed Z, Isaacs AM, Brelstaff JH, Borroni B, Warren JD, Troakes C, King A, Al-Saraj S, Newcombe J, Quinn N, Ostergaard K, Schrøder HD, Bojsen-Møller M, Braendgaard H, Fox NC, Rossor MN, Lees AJ, Holton JL, Revesz T.

Brain. 2011 Sep;134(Pt 9):2548-64. doi: 10.1093/brain/awr160. Epub 2011 Jul 12.

PMID:
21752791
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Distinct pathological subtypes of FTLD-FUS.

Mackenzie IR, Munoz DG, Kusaka H, Yokota O, Ishihara K, Roeber S, Kretzschmar HA, Cairns NJ, Neumann M.

Acta Neuropathol. 2011 Feb;121(2):207-18. doi: 10.1007/s00401-010-0764-0. Epub 2010 Oct 30.

PMID:
21052700
[PubMed - indexed for MEDLINE]
4.

Frontotemporal lobar degeneration: diversity of FTLD lesions.

Seilhean D, Bielle F, Plu I, Duyckaerts C.

Rev Neurol (Paris). 2013 Oct;169(10):786-92. doi: 10.1016/j.neurol.2013.07.015. Epub 2013 Sep 12. Review.

PMID:
24035575
[PubMed - indexed for MEDLINE]
5.

The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.

Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, Momeni P, Baborie A, Griffiths TD, Jaros E, Perry RH, Richardson A, Pickering-Brown SM, Neary D, Mann DM.

Acta Neuropathol. 2011 Jul;122(1):99-110. doi: 10.1007/s00401-011-0816-0. Epub 2011 Mar 20.

PMID:
21424531
[PubMed - indexed for MEDLINE]
6.

TDP-43 variants of frontotemporal lobar degeneration.

Bigio EH.

J Mol Neurosci. 2011 Nov;45(3):390-401. doi: 10.1007/s12031-011-9545-z. Epub 2011 May 24.

PMID:
21607722
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects.

Halliday G, Bigio EH, Cairns NJ, Neumann M, Mackenzie IR, Mann DM.

Acta Neuropathol. 2012 Sep;124(3):373-82. doi: 10.1007/s00401-012-1030-4. Epub 2012 Aug 10. Review.

PMID:
22878865
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.

Collins M, Riascos D, Kovalik T, An J, Krupa K, Krupa K, Hood BL, Conrads TP, Renton AE, Traynor BJ, Bowser R.

Acta Neuropathol. 2012 Nov;124(5):717-32. doi: 10.1007/s00401-012-1045-x. Epub 2012 Sep 21.

PMID:
22993125
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.

Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E, Troakes C, Al-Sarraj S, King A, Borroni B, Clarkson MJ, Ourselin S, Holton JL, Fox NC, Revesz T, Rossor MN, Warren JD.

Brain. 2011 Sep;134(Pt 9):2565-81. doi: 10.1093/brain/awr198.

PMID:
21908872
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.

Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE; FReJA Consortium, Dickson DW, Rademakers R, Graff-Radford NR, Parisi JE, Petersen RC, Hatanpaa KJ, White CL 3rd, Weiner MF, Geser F, Van Deerlin VM, Trojanowski JQ, Miller BL, Seeley WW, van der Zee J, Kumar-Singh S, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bigio EH, Deng HX, Halliday GM, Kril JJ, Munoz DG, Mann DM, Pickering-Brown SM, Doodeman V, Adamson G, Ghazi-Noori S, Fisher EM, Holton JL, Revesz T, Rossor MN, Collinge J, Mead S, Isaacs AM.

Acta Neuropathol. 2010 Jul;120(1):33-41. doi: 10.1007/s00401-010-0698-6. Epub 2010 May 20.

PMID:
20490813
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.

Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, Roeber S, Kretzschmar HA, Munoz DG, Kusaka H, Yokota O, Ang LC, Bilbao J, Rademakers R, Haass C, Mackenzie IR.

Brain. 2011 Sep;134(Pt 9):2595-609. doi: 10.1093/brain/awr201. Epub 2011 Aug 19.

PMID:
21856723
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.

Seelaar H, Klijnsma KY, de Koning I, van der Lugt A, Chiu WZ, Azmani A, Rozemuller AJ, van Swieten JC.

J Neurol. 2010 May;257(5):747-53. doi: 10.1007/s00415-009-5404-z. Epub 2009 Nov 28.

PMID:
19946779
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A new subtype of frontotemporal lobar degeneration with FUS pathology.

Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR.

Brain. 2009 Nov;132(Pt 11):2922-31. doi: 10.1093/brain/awp214. Epub 2009 Aug 11.

PMID:
19674978
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

FUS pathology in basophilic inclusion body disease.

Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, Terada S, Kuroda S, Mackenzie IR.

Acta Neuropathol. 2009 Nov;118(5):617-27. doi: 10.1007/s00401-009-0598-9. Epub 2009 Oct 15.

PMID:
19830439
[PubMed - indexed for MEDLINE]
15.

Phenotypic variability within the inclusion body spectrum of basophilic inclusion body disease and neuronal intermediate filament inclusion disease in frontotemporal lobar degenerations with FUS-positive inclusions.

Gelpi E, Lladó A, Clarimón J, Rey MJ, Rivera RM, Ezquerra M, Antonell A, Navarro-Otano J, Ribalta T, Piñol-Ripoll G, Pérez A, Valldeoriola F, Ferrer I.

J Neuropathol Exp Neurol. 2012 Sep;71(9):795-805. doi: 10.1097/NEN.0b013e318266efb1.

PMID:
22892522
[PubMed - indexed for MEDLINE]
16.

Frontotemporal lobar degeneration with ubiquitinated tau-negative inclusions and additional alpha-synuclein pathology but also unusual cerebellar ubiquitinated p62-positive, TDP-43-negative inclusions.

King A, Al-Sarraj S, Shaw C.

Neuropathology. 2009 Aug;29(4):466-71. doi: 10.1111/j.1440-1789.2008.00966.x. Epub 2008 Aug 18.

PMID:
18715271
[PubMed - indexed for MEDLINE]
17.

Frontotemporal dementia: implications for understanding Alzheimer disease.

Goedert M, Ghetti B, Spillantini MG.

Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006254. doi: 10.1101/cshperspect.a006254. Review.

PMID:
22355793
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).

Bentmann E, Neumann M, Tahirovic S, Rodde R, Dormann D, Haass C.

J Biol Chem. 2012 Jun 29;287(27):23079-94. doi: 10.1074/jbc.M111.328757. Epub 2012 May 4.

PMID:
22563080
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[The molecular pathology of frontotemporal lobar degeneration].

Fujishiro H, Hasegawa M, Arai T.

Seishin Shinkeigaku Zasshi. 2010;112(4):313-24. Review. Japanese.

PMID:
20496755
[PubMed - indexed for MEDLINE]
20.

Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.

Armstrong RA, Hamilton RL, Mackenzie IR, Hedreen J, Cairns NJ.

Neuropathol Appl Neurobiol. 2013 Jun;39(4):335-47. doi: 10.1111/j.1365-2990.2012.01291.x.

PMID:
22804696
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk